77 related articles for article (PubMed ID: 17149700)
1. RACK1 regulates Ki-Ras-mediated signaling and morphological transformation of NIH 3T3 cells.
Bjørndal B; Myklebust LM; Rosendal KR; Myromslien FD; Lorens JB; Nolan G; Bruland O; Lillehaug JR
Int J Cancer; 2007 Mar; 120(5):961-9. PubMed ID: 17149700
[TBL] [Abstract][Full Text] [Related]
2. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
3. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
4. ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.
Posada IM; Serulla M; Zhou Y; Oetken-Lindholm C; Abankwa D; Lectez B
PLoS One; 2016; 11(7):e0159677. PubMed ID: 27437940
[TBL] [Abstract][Full Text] [Related]
5. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Zebisch A; Staber PB; Delavar A; Bodner C; Hiden K; Fischereder K; Janakiraman M; Linkesch W; Auner HW; Emberger W; Windpassinger C; Schimek MG; Hoefler G; Troppmair J; Sill H
Cancer Res; 2006 Apr; 66(7):3401-8. PubMed ID: 16585161
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-stimulated formation of ethanolamine from phosphatidylethanolamine involves a protein phosphorylation mechanism: negative regulation by p21 Ras protein.
Deli E; Kiss Z
Arch Biochem Biophys; 2000 May; 377(1):171-7. PubMed ID: 10775457
[TBL] [Abstract][Full Text] [Related]
8. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
9. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
[TBL] [Abstract][Full Text] [Related]
10. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
11. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
12. Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.
Wang Y; Tong Y; Tso PH; Wong YH
Cancer Lett; 2013 Oct; 339(1):33-41. PubMed ID: 23911936
[TBL] [Abstract][Full Text] [Related]
13. Activation of phospholipase D by 8-Br-cAMP occurs through novel pathway involving Src, Ras, and ERK in human endometrial stromal cells.
Yoon MS; Koo JB; Hwang JH; Lee KS; Han JS
FEBS Lett; 2005 Oct; 579(25):5635-42. PubMed ID: 16214133
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.
Reed JC; Yum S; Cuddy MP; Turner BC; Rapp UR
Cell Growth Differ; 1991 May; 2(5):235-43. PubMed ID: 1888699
[TBL] [Abstract][Full Text] [Related]
16. Farnesyl pyrophosphate promotes and is essential for the binding of RACK1 with beta-tubulin.
Huang CF; Fan JH; Chuang NN
J Exp Zool A Comp Exp Biol; 2003 Aug; 298(2):119-27. PubMed ID: 12884273
[TBL] [Abstract][Full Text] [Related]
17. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
[TBL] [Abstract][Full Text] [Related]
18. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
[TBL] [Abstract][Full Text] [Related]
19. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.
Najumudeen AK; Posada IM; Lectez B; Zhou Y; Landor SK; Fallarero A; Vuorela P; Hancock J; Abankwa D
Biochemistry; 2015 Dec; 54(49):7212-21. PubMed ID: 26568031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
